Randomized comparison of nab-paclitaxel weekly or every 3 weeks compared to docetaxel every 3 weeks as first-line therapy in patients (pts) with metastatic breast cancer (MBC)

✍ Scribed by W. Gradishar; D. Krasnojon; S. Cheporov; A. Makhson; G. Manikhas; A. Clawson; P. Bhar

• Book ID: 119598217
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 61 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)70725-0